News search

    E.g., 01/07/2025
    E.g., 01/07/2025
    Dr. José María Mendiguren, Director de Servicios Médicos de Banco Santander, Leticia Fernández-Friera, cardióloga del CNIC y del Hospital Universitario HM Montepríncipe, y Dr. Valentín Fuster, Director del CNIC.
    Research
    26 Mar 2019
    JACC: Advanced imaging technology predicts cardiovascular risk from inflammation detected in arteries

    The results, published in JACC, demonstrate the potential of this technology to generate images of the inflammation associated with systemic atherosclerosis; this information will be useful for the study of early stages of this disease and will help to identify individuals who will benefit from early medical intervention
    Pilar Gonzalo, Rosa Nevado, Ricardo Villa-Bellosta, Magda R. Hamczyk, María J. Andrés-Manzano, and Vicente Andrés.
    Research
    12 Mar 2019
    EMBO Molecular Medicine: CNIC scientists discover a new therapeutic target for blocking early atherosclerosis in progeria

    This new results, published in EMBO Molecular Medicine, identify a possible therapeutic target for this genetic disease
    Borja Ibáñez, Carlos Galán, Rodrigo Fernández, Eduardo Oliver, Gonzalo Pizarro, Manuel Lobo, Jean Paul Vilchez Tschischke, Antonio de Molina-Iracheta, Rocío Villena y Javier Sánchez-González
    Research
    19 Feb 2019
    JACC: Identified a very early marker of cardiac damage triggered by cancer treatment

    The results have implications for patient prognosis, since detection of this marker can prompt intervention to prevent irreversible damage
    Research
    16 Jan 2019
    JACC: The duration and quality of sleep is of vital importance in cardiovascular health

    Poor quality sleep increases the risk of atherosclerosis according to the PESA CNIC- Santander Study published in the Journal of the American College of Cardiology (JACC)
    Photo
    Research
    8 Jan 2019
    Circulation: Expression of a molecule in blood cells predicts atherosclerosis risk

    The expression on lymphocytes of the molecule CD69 inversely predicts the development of subclinical (symptom-free) atherosclerosis independently of classical cardiovascular risk factors
    Foto
    Research
    19 Nov 2018
    The CNIC Conference addresses the emerging concepts of cardiovascular biology

    The scientific event, which took place in Madrid, brought together more than 100 researchers from different fields of cardiovascular biology

    Research
    16 Nov 2018
    Nature Communications: Blocking hypertension with antihypertensive drugs prevents the development of a lethal disease

    The study results, published in the journal Nature Communications, identify several proteins implicated in this disease
    From left to right: David Sancho, Carlos del Fresno, Paula Saz, and Sarai Martínez Cano.
    Research
    19 Oct 2018
    Science: A new mechanism in the control of inflammation

    CNIC researchers have discovered a new inflammatory control mechanism that paves the way to controlling injury generated during the immune response

    About the CNIC
    1 Oct 2018
    CNIC researcher Guadalupe Sabio receives the IV AstraZeneca Foundation Jóvenes Investigadores prize

    The Fundación AstraZeneca young researcher awards were created to give scientists the opportunities they deserve
    Bertie Göttgens y Miguel Manzanares
    About the CNIC
    27 Jul 2018
    Bertie Göttgens: "Communication between basic and clinical research is complex "

    Dr. Göttgens gave the conference "Cellular States, Differentiation Trajectories and Regulatory Networks of Blood Cell Development" at the CNIC Seminar cycle, invited by Dr. Miguel Manzanares.